Resources>Citations Database>Self-delivery of TIGIT-blocking scFv enhances CAR-T immunotherapy in solid tumors

Self-delivery of TIGIT-blocking scFv enhances CAR-T immunotherapy in solid tumors

Biointron 2023-06-09

Authors: Fan Yang, Fan Zhang, Feng Ji, Jiannan Chen, Jun Li, Zhengliang Chen, Zhigang Hu, and Zhigang Guo

Journal: Frontiers in Immunology

DOI: https://doi.org/10.3389/fimmu.2023.1175920

Products & Services: TIGIT antibody (100 μg/per mice) (Biointron)

Recommended Articles
MRNA Profiling Involved in Triggering of STAT1 with Regulatory Involvement of IRF7, PTPRF, and miR-145p in Patients Suffering from Gall Bladder Carcinoma
Nov 25, 2025
Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybrids for Drug Delivery

Droplet Squeeze Microfluidic Platform for Generating Extracellular Vesicle Hybri……

Aug 07, 2025
Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of Multiple Myeloma

Self-Assembling Multi-Antigen T Cell Hybridizers for Precision Immunotherapy of ……

Aug 01, 2025
Inhibition of long-lived plasma cells, a critical role for Telitacicept treatment to systemic lupus erythematosus

Inhibition of long-lived plasma cells, a critical role for Telitacicept treatmen……

Jul 30, 2025

Our website uses cookies to improve your experience. Read our Privacy Policy to find out more.